Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study.

[1]  A. Hofman,et al.  Cerebral Microbleeds Are Associated With an Increased Risk of Stroke: The Rotterdam Study , 2015, Circulation.

[2]  G. Paolisso,et al.  Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. , 2013, Journal of the American College of Cardiology.

[3]  S. Shimizu,et al.  Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation. , 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[4]  S. Yusuf,et al.  Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies , 2012, Canadian Medical Association Journal.

[5]  Eric E. Smith,et al.  Cerebral microinfarcts: the invisible lesions , 2012, The Lancet Neurology.

[6]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[7]  Jun Zhu,et al.  Apixaban in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[8]  C. Sudlow,et al.  Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage: A Systematic Review of Published and Unpublished Studies , 2010, Stroke.

[9]  S. Yusuf,et al.  Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. , 2010, American heart journal.

[10]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[11]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[12]  R. D'Agostino,et al.  Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.

[13]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[14]  G. Guyatt,et al.  Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study , 2006, The Lancet Neurology.

[15]  B. Lüderitz,et al.  Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  L. Wilkins.  Oral Anticoagulation in Patients After Cerebral Ischemia of Arterial Origin and Risk of Intracranial Hemorrhage , 2003, Stroke.

[17]  Jia Liu,et al.  Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages , 2003, Neurology.

[18]  Matthijs Oudkerk,et al.  Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.

[19]  Curt D. Furberg,et al.  Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2002, Stroke.

[20]  K. Furie,et al.  A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.

[21]  A. Hofman,et al.  Cerebral white matter lesions and cognitive function: The Rotterdam scan study , 2000, Annals of neurology.

[22]  T. Manolio,et al.  Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. , 1998, Archives of neurology.

[23]  David C. Anderson,et al.  Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation , 1996, Neurology.

[24]  M. Ezekowitz,et al.  Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1995, Circulation.

[25]  C. Helgason.  Cardioembolic stroke: topography and pathogenesis. , 1992, Cerebrovascular and brain metabolism reviews.